SCOOT: Sample Collection for DART
NCT05368298
Summary
The study will use a blood sample collected from participants to: * Develop new ways of finding and diagnosing lung health problems, such as lung cancer. * Develop tools which make it easier to screen people with possible lung health problems, diagnose problems earlier and with fewer tests, and start the best treatment faster. * Help improve the early diagnosis of lung cancer, as finding lung cancer early means that it can be treated more easily and successfully.
Eligibility
Patient suitability will be assessed against the below criteria by the clinical teams managing the patients. Inclusion Criteria: 1. Patients with a pulmonary nodule or nodule(s) detected on a CT scan performed as part of Lung Cancer Screening from the Lung Health Check centres, that require further investigation with a PET-CT scan, and / or biopsy, and / or resection 2. Willing and able to give informed consent Exclusion Criteria: * None -
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05368298